FI940041A7 - Morfinaanien o-aryylieettereitä - Google Patents
Morfinaanien o-aryylieettereitä Download PDFInfo
- Publication number
- FI940041A7 FI940041A7 FI940041A FI940041A FI940041A7 FI 940041 A7 FI940041 A7 FI 940041A7 FI 940041 A FI940041 A FI 940041A FI 940041 A FI940041 A FI 940041A FI 940041 A7 FI940041 A7 FI 940041A7
- Authority
- FI
- Finland
- Prior art keywords
- morphinans
- aryl ethers
- ethers
- aryl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US113593A | 1993-01-06 | 1993-01-06 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI940041A0 FI940041A0 (fi) | 1994-01-05 |
| FI940041A7 true FI940041A7 (fi) | 1994-07-07 |
| FI940041L FI940041L (fi) | 1994-07-07 |
Family
ID=21694554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI940041A FI940041L (fi) | 1993-01-06 | 1994-01-05 | Morfinaanien o-aryylieettereitä |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0612730B1 (OSRAM) |
| JP (1) | JP2501298B2 (OSRAM) |
| KR (1) | KR940018094A (OSRAM) |
| CN (1) | CN1097006A (OSRAM) |
| AT (1) | ATE154931T1 (OSRAM) |
| AU (1) | AU681601B2 (OSRAM) |
| BR (1) | BR9400021A (OSRAM) |
| CA (1) | CA2110337A1 (OSRAM) |
| CZ (1) | CZ2294A3 (OSRAM) |
| DE (1) | DE69311887T2 (OSRAM) |
| DK (1) | DK0612730T3 (OSRAM) |
| ES (1) | ES2105061T3 (OSRAM) |
| FI (1) | FI940041L (OSRAM) |
| GR (1) | GR3024891T3 (OSRAM) |
| HU (2) | HUT66061A (OSRAM) |
| IL (1) | IL108247A (OSRAM) |
| MX (1) | MX9400177A (OSRAM) |
| NO (1) | NO940028D0 (OSRAM) |
| NZ (1) | NZ250580A (OSRAM) |
| PL (1) | PL175365B1 (OSRAM) |
| TW (1) | TW264473B (OSRAM) |
| UY (1) | UY23706A1 (OSRAM) |
| ZA (1) | ZA939806B (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9522176D0 (en) * | 1995-10-30 | 1996-01-03 | Iaf Biochem Int | Morphinan derivatives having neuroprotective activity |
| EP0812827B1 (en) * | 1996-06-13 | 2009-09-02 | Sumitomo Chemical Company, Limited | Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation |
| FR2752163B1 (fr) * | 1996-08-12 | 1998-10-30 | Pf Medicament | Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington |
| GB9706753D0 (en) * | 1997-04-03 | 1997-05-21 | Pharmacia & Upjohn Spa | Aralkoxy-morphinan derivatives |
| KR100425881B1 (ko) * | 2001-03-14 | 2004-04-03 | 고광호 | 신규한 몰피난 유도체 |
| MXPA04011327A (es) * | 2002-05-17 | 2005-08-15 | Jenken Biosciences Inc | Opioides y compuestos similares a opioides y usos de los mismos. |
| DE10229842A1 (de) * | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
| US20040204862A1 (en) | 2003-04-11 | 2004-10-14 | Wainer Irving W. | Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| JP5784507B2 (ja) * | 2009-02-23 | 2015-09-24 | マリンクロッド エルエルシー | （＋）−モルフィナニウム第四級塩およびその生成方法 |
| CN103044327B (zh) * | 2013-01-07 | 2014-12-17 | 苏州立新制药有限公司 | 一种右美沙芬的制备方法 |
| SG11201701645WA (en) * | 2014-09-14 | 2017-04-27 | Avanir Pharmaceuticals Inc | Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementia |
| WO2016138103A1 (en) * | 2015-02-25 | 2016-09-01 | Alkermes, Inc. | Treatments for alzheimer's related diseases and disorders |
| KR20230044470A (ko) * | 2020-08-28 | 2023-04-04 | 닛뽕 케미파 가부시키가이샤 | 신규한 구리 촉매를 사용하여 디아릴 에테르 골격을 갖는 모르피난 유도체를 제조하는 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4113729A (en) * | 1976-12-06 | 1978-09-12 | Hoffmann-La Roche Inc. | 3-Phenoxymorphinans and derivatives thereof |
| FI773636A7 (fi) * | 1976-12-06 | 1978-06-07 | Hoffmann La Roche | Nya fenylderivat |
| US4806543A (en) * | 1986-11-25 | 1989-02-21 | Board Of Trustees Of The Leland Stanford Junior University | Method and compositions for reducing neurotoxic injury |
-
1993
- 1993-11-25 TW TW082109942A patent/TW264473B/zh active
- 1993-11-30 CA CA002110337A patent/CA2110337A1/en not_active Abandoned
- 1993-12-20 EP EP93120498A patent/EP0612730B1/en not_active Expired - Lifetime
- 1993-12-20 ES ES93120498T patent/ES2105061T3/es not_active Expired - Lifetime
- 1993-12-20 DE DE69311887T patent/DE69311887T2/de not_active Expired - Fee Related
- 1993-12-20 DK DK93120498.6T patent/DK0612730T3/da active
- 1993-12-20 AT AT93120498T patent/ATE154931T1/de not_active IP Right Cessation
- 1993-12-23 NZ NZ250580A patent/NZ250580A/en unknown
- 1993-12-30 JP JP5354172A patent/JP2501298B2/ja not_active Expired - Lifetime
- 1993-12-30 ZA ZA939806A patent/ZA939806B/xx unknown
- 1993-12-31 UY UY23706A patent/UY23706A1/es unknown
- 1993-12-31 IL IL108247A patent/IL108247A/en not_active IP Right Cessation
- 1993-12-31 AU AU52807/93A patent/AU681601B2/en not_active Ceased
-
1994
- 1994-01-03 HU HU9400002A patent/HUT66061A/hu unknown
- 1994-01-03 MX MX9400177A patent/MX9400177A/es not_active IP Right Cessation
- 1994-01-04 NO NO940028A patent/NO940028D0/no unknown
- 1994-01-04 KR KR1019940000067A patent/KR940018094A/ko not_active Ceased
- 1994-01-05 CN CN94100181A patent/CN1097006A/zh active Pending
- 1994-01-05 PL PL94301784A patent/PL175365B1/pl unknown
- 1994-01-05 FI FI940041A patent/FI940041L/fi unknown
- 1994-01-05 CZ CZ9422A patent/CZ2294A3/cs unknown
- 1994-01-05 BR BR9400021A patent/BR9400021A/pt not_active Application Discontinuation
-
1995
- 1995-06-19 HU HU95P/P00253P patent/HU211290A9/hu unknown
-
1997
- 1997-09-30 GR GR970402538T patent/GR3024891T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0612730T3 (da) | 1998-02-02 |
| NZ250580A (en) | 1996-07-26 |
| HU9400002D0 (en) | 1994-05-30 |
| HUT66061A (en) | 1994-09-28 |
| JP2501298B2 (ja) | 1996-05-29 |
| CZ2294A3 (en) | 1994-07-13 |
| KR940018094A (ko) | 1994-08-16 |
| EP0612730B1 (en) | 1997-07-02 |
| TW264473B (OSRAM) | 1995-12-01 |
| MX9400177A (es) | 1994-07-29 |
| NO940028D0 (no) | 1994-01-04 |
| AU681601B2 (en) | 1997-09-04 |
| HU211290A9 (en) | 1995-11-28 |
| CA2110337A1 (en) | 1994-07-07 |
| DE69311887T2 (de) | 1998-01-15 |
| NO940028L (OSRAM) | 1994-07-07 |
| ZA939806B (en) | 1994-07-06 |
| CN1097006A (zh) | 1995-01-04 |
| AU5280793A (en) | 1994-07-14 |
| BR9400021A (pt) | 1994-07-26 |
| UY23706A1 (es) | 1994-06-05 |
| FI940041A0 (fi) | 1994-01-05 |
| PL301784A1 (en) | 1994-07-11 |
| ES2105061T3 (es) | 1997-10-16 |
| PL175365B1 (pl) | 1998-12-31 |
| ATE154931T1 (de) | 1997-07-15 |
| IL108247A (en) | 1998-02-22 |
| FI940041L (fi) | 1994-07-07 |
| EP0612730A1 (en) | 1994-08-31 |
| IL108247A0 (en) | 1994-04-12 |
| GR3024891T3 (en) | 1998-01-30 |
| DE69311887D1 (de) | 1997-08-07 |
| JPH06316564A (ja) | 1994-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69431193D1 (en) | Hiv - protease inhibitoren | |
| DE69310962D1 (de) | Epoxydierungsverfahren | |
| DE69333845D1 (de) | Axiallüfter | |
| FI934051A7 (fi) | (S)-(+)-hydroksiklorokiini | |
| GB9223173D0 (en) | Drawing instrument | |
| FI932105A7 (fi) | Sulfonyylibentsyylisubstituoituja bentso- ja pyridopyridoneja | |
| FI940041L (fi) | Morfinaanien o-aryylieettereitä | |
| BR9302876A (pt) | Conjunto de interface | |
| BR9304691A (pt) | Processo de preparaçao de argamassa | |
| MX9102079A (es) | Plemezcla de semduramicina | |
| GB2273081B (en) | Drawing instrument | |
| GB9005789D0 (en) | Masking | |
| KR950002536U (ko) | 간이 실드 롬(Shield Room) | |
| ITMI931614A1 (it) | Filatoio | |
| FI931255L (fi) | Avisar/nedisar -aemne | |
| KR930025062U (ko) | 지압기 | |
| UA30S (uk) | Склянка | |
| BR9200406A (pt) | Relogio de esferas | |
| BR9200148A (pt) | Gincana de frases | |
| SV1993000010A (es) | Preparacion de nuevas sulfonamidocarboxamidas | |
| BR9202623A (pt) | Jogo de combinacoes de esferas | |
| IT8919085A0 (it) | Amedeo dognini | |
| KR940000460U (ko) | 골프형 놀이기구 | |
| BR9102359A (pt) | Loteria instantanea de simbolos | |
| ITLU920012V0 (it) | Aumento della distanza percorsa con lo stesso numero di pedalate |